Everolimus Tablet
Product Images NDC 49884-159

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 49884-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Everolimus Tabs 1)

FDA Label Image

1 mg Carton Principle Display Panel (Everolimus Tabs 10)

This is a medication guide for Everolimus tablets, which are prescription drugs. It contains the dosage and storage instructions, and it's essential to dispense this guide to every patient. The tablets come in blister cards, and each card contains ten tablets. The manufacturer is Par Pharmaceutical, located in Chestnut Ridge, NY. Side effects should be reported to 1-800-FDA-1088. Keep this medication and all drugs away from children.*

FDA Label Image

Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73m2] By Visit Window And Treatment (itt Population 24 Month Analysis)* (Everolimus Tabs 2)

FDA Label Image

0.25 mg Blister Pack (Everolimus Tabs 3)

The text mentions Everolimus Tablets manufactured by PAR Pharmaceutical with address in Chestnut Ridge, NY 10977. The text also contains some errors and repetitions.*

FDA Label Image

0.5 mg Blister Pack (Everolimus Tabs 4)

Everolimus Tablet is a medication available in 2mg and 5mg formulations. It is manufactured by Par Pharmaceutical and is used for the treatment of certain types of cancer.*

FDA Label Image

0.75 mg Blister Pack (Everolimus Tabs 5)

This text seems to be a list of descriptions of Everolimus Tablet with details like the name of the medicine, the dosage, and other details like the company name, address, and product code. However, due to the errors in the text, the exact details of the dosage and other critical information can't be inferred.*

FDA Label Image

1 mg Blister Pack Principle Diplay Panel (Everolimus Tabs 6)

The text is not readable.*

FDA Label Image

Carton_0.25 mg (Everolimus Tabs 7)

This is a prescription medication with the generic name everolimus, and each tablet contains 0.25 mg of the drug. The contents of the package are 6 blister cards, each containing 10 tablets. The manufacturer is Par Pharmaceutical. It is necessary to keep the drug out of reach of children and store it at a temperature of 25°C (77°F) with limited excursions. More details on dosage can be obtained from the package insert, and instructions on dispensing the medication should be given to each patient. The product has an NDC code of 49884-158-02. The text also includes a warning to consult a doctor if there are any side effects and an FDA reporting hotline number.*

FDA Label Image

Carton_0.5 mg (Everolimus Tabs 8)

This is a description about Everolimus Tablets, the NDC code is 49884-159-02 and it contains 0.5mg per tablet. The recommended storage is at a temperature of 25°C and it should be protected from light and moisture. The medication guide should be given to each patient and kept out of reach of children. The medicine is manufactured by LT el p- in Chestnut Ridge, NY 10977. Side effects can be reported to the FDA. Dosage information can be found in the package insert.*

FDA Label Image

Carton_0.75 mg (Everolimus Tabs 9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.